Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option
The Pharmacy Compounding Advisory Committee is scheduled to review BPC-157 on July 23, 2026 for possible inclusion on the 503A bulks list
Complete your health questionnaire online Let us know about any medications youre taking Drink plenty of water and skip alcohol the day before Bring any questions about your health goals Dont skip your doses consistency is key Keep your peptides in the fridge Stay hydrated If you experience an emergency, call 911 Come to all your follow-up appointments so we can track your progress When it comes to your health and results, we believe in transparency and proofnot just promises
A patient with a tendon injury, ligament tear, inflammatory condition, nerve problem, autoimmune issue, infection, or structural joint damage may need different care
